EverGlade Consulting in the Media

Amendment to BAA Outlines New BARDA Funding Opportunities for Next-generation COVID-19 Vaccines, Monoclonal Antibodies, and Antivirals

In the latest amendment to its Broad Agency Announcement (BAA), BARDA (Biomedical Advanced Research and Development Authority) is seeking proposals for the development of cost-effective and adaptable therapeutic platforms to treat viral infections, as well as next-generation COVID-19 vaccines.

EverGlade Consulting Funding Alert: CHIPS Act Funding Opportunity for Tech Hubs Program

The United States Economic Development Administration (EDA) released a Notice of Funding Opportunity (NOFO) for Regional Technology and Innovation Hubs (Tech Hubs). This initiative aims to foster innovation, collaboration, and economic growth by establishing regional technology hubs across the nation by providing funding and resources to create and expand technology-focused hubs.

EverGlade Consulting Assists Appili Therapeutics in Successful Pursuit of DTRA Funding

EverGlade Consulting (“EverGlade”), a national consulting firm, has helped Appili Therapeutics USA Inc. (“Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, secure an initial contract with the U.S. Air Force Academy (USAFA). USAFA is the prime contractor to DTRA for this program. 

EverGlade Consulting Funding Alert: Biden Administration Announces Launch of Successor Program to Operation Warp Speed

CHARLESTON, S.C., April 12, 2023 /PRNewswire/ — Project Next Gen is a new program launched by the Biden administration aimed at accelerating the development of new coronavirus vaccines and treatments.

EverGlade Consulting: CHIPS for America Launches First Funding Opportunity (Commercial Fabrication Facilities)

The US Department of Commerce has opened the application process for companies to revitalize the domestic semiconductor industrial base. The move is aimed at securing a share of the multi-billion-dollar semiconductor opportunity by 2030 and strengthening leadership in chip manufacturing.

EverGlade Consulting Founder, Eric Jia-Sobota, Announces Promotions, New Hires and 20% Growth in Q12023

EverGlade Consulting (“EverGlade”), a national consulting firm, announces key promotions and new hires while achieving 20% growth in the first quarter of 2023.

Prepaire Appoints Everglade Consulting to Secure Non-Dilutive Federal Government Funding for Multiple Projects

Prepaire Labs, an AI-driven biotechnology company powering drug discovery, repurposing, designing, and development, today announced the appointment of Everglade Consulting, a national consulting firm assisting biotechnology companies to secure non-dilutive federal funding.

EverGlade Consulting Helps Land up to $1 Billion in BARDA Funding for Biotechnology Company

EverGlade Consulting has helped a leading biotechnology company land an award from the Biomedical Advanced Research and Development Authority (BARDA) with a potential $1 billion in federal funding.

EverGlade Consulting Launches DOE Loan and CHIPS Support Practices

EverGlade Consulting (“EverGlade”), a national consulting firm, with employees in locations across the country, has launched two new practices to support recent legislation. EverGlade has been on the forefront of U.S. Government (“USG”) efforts to broaden the nation’s domestic industrial base to accommodate the manufacturing of critical supplies and materials.

EverGlade Consulting opens Washington, DC office

The Charleston, SC-headquartered firm said the DC office was a “logical next location for a physical presence.” EverGlade has already cut the ribbon on the office and is planning to recruit for roles in regulatory affairs, quality assurance, program management, project management, and government contract administration and compliance.

Scroll to Top